loader2
Partner With Us NRI

Company details

393.75
402.20
386.30
690.60
6M Return -16.77%
1Y Return -33.80%
Mkt Cap.(Cr) 11,340.33
Volume 11,402
Div Yield 0.61%
OI
-
OI Chg %
-
Volume 11,402

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding


EMA SMA

Delivery and volume

Our Research View

Trading recommendation

Data not found

Investment recommendation

Call Date

06 Apr 2022

Entry Price

464.00

Target Price

550.00

Duration

3 Month

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 7,064.63 Cr FV: 1.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 22,733.13 -38,577.79
LAST 3M 77,375.96 -53,201.90
LAST 6M 142,231.38 -196,897.34
LAST 12M 206,053.08 -176,593.86

Information

  • About Company
  • Company Info
  • Listing Info
10.32
46.65%
306.9529
14.75%
14.77%

Registered Address

B/2 Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai, Maharashtra, 400026

Tel : 91-22-40189999
Email : complianceofficer:glenmarkpharma.com
Website : http://www.glenmarkpharma.com

Registrar

Karvy Computershare Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 1
Market Lot Equity Shares : 1
BSE Code : 532296
NSE Code : GLENMARK
Book Closure Date (Month) : Sep
BSE Group : A
ISIN : INE935A01035

ICICIdirect Glenmark Pharmaceuticals Ltd FAQ

You can buy Glenmark Pharmaceuticals Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Glenmark Pharmaceuticals Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of May 23, 2022 10:10 AM the closing price of Glenmark Pharmaceuticals Ltd was ₹ 401.90.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of May 23, 2022 10:10 AM, the market cap of Glenmark Pharmaceuticals Ltd stood at ₹ 11,340.33.
The latest PE ratio of Glenmark Pharmaceuticals Ltd as of May 23, 2022 10:10 AM is 10.32
The latest PB ratio of Glenmark Pharmaceuticals Ltd as of May 23, 2022 10:10 AM is 0.75
The 52-week high of Glenmark Pharmaceuticals Ltd is ₹ 690.60 while the 52-week low is ₹ 386.30 .
According to analyst recommendations, Glenmark Pharmaceuticals Ltd has a “Buy” rating for the long term.

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE